GKB Ophthalmics share price
NSE: GKBFMCGMedical Instruments & Supplies
GKB Ophthalmics at a glance
GKB Ophthalmics (NSE: GKB) closed at ₹60.00 on 22 Oct 2026, up 0.00% on the day. With a market capitalisation of ₹30 Cr, it ranks 3368th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Medical Instruments & Supplies.
At its last close the stock traded at 24.8× trailing earnings, against a return on equity of 2.3% in FY26. Its 52-week range is ₹58.10 (21 Oct 2026) to ₹76.02 (22 Sep 2026); the last close is 21.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹30 Cr (−4.0% year on year) and net profit ₹1 Cr, on a consolidated basis. Promoters held 51.15% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹30 CrRank 3368 on NSE
- P/E (trailing)
- 24.8×
- Price to book
- 0.5×FY26
- EPS (TTM)
- ₹2.41to Q4 FY26
- ROE
- 2.3%FY26
- ROCE
- 12.5%FY26
- Debt to equity
- 0.22FY26
- Net profit margin
- 2.1%FY26
- Book value / share
- ₹104.82FY26
- 52-week high
- ₹76.0222 Sep 2026
- 52-week low
- ₹58.1021 Oct 2026
- RSI (14-day)
- 40.7
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | 0.00% | −5.1% | −13.9% | — | — |
GKB Ophthalmics quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹31 Cr | ₹32 Cr | ₹30 Cr | ₹57 Cr | ₹30 Cr |
| Revenue YoY | +16.9% | +28.1% | +7.3% | +43.9% | +24.2% | +15.4% | +120.1% | −4.0% |
| Net profit | −₹0 Cr | −₹1 Cr | −₹2 Cr | −₹4 Cr | −₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| Net profit YoY | −107.3% | — | — | — | — | — | — | — |
| Net margin | −0.2% | −4.6% | −7.3% | −13.3% | −1.9% | 6.2% | 1.2% | 3.9% |
| EPS | ₹0.50 | −₹2.41 | −₹4.03 | −₹7.03 | −₹2.02 | ₹3.17 | ₹0.88 | ₹0.38 |
GKB Ophthalmics financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹57 Cr | ₹71 Cr | ₹75 Cr | ₹88 Cr | ₹109 Cr | — |
| Operating profit | −₹1 Cr | ₹2 Cr | ₹0 Cr | −₹3 Cr | −₹7 Cr | — |
| Net profit | −₹1 Cr | ₹2 Cr | ₹0 Cr | −₹3 Cr | −₹7 Cr | — |
| EPS (₹) | −₹2.00 | ₹3.00 | ₹0.00 | −₹6.00 | −₹14.00 | — |
| Cash from operations | −₹4 Cr | ₹5 Cr | −₹3 Cr | ₹4 Cr | −₹3 Cr | — |
| Total debt | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr |
| Shareholders' equity | ₹63 Cr | ₹63 Cr | ₹63 Cr | ₹60 Cr | ₹52 Cr | ₹53 Cr |
GKB Ophthalmics shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 50.99% | 51.06% | 51.06% | 51.13% | 51.13% | 51.15% |
| Foreign institutions | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% |
| Non-institutions | 47.23% | 47.16% | 47.16% | 47.09% | 47.09% | 47.07% |
GKB Ophthalmics vs peers
The listed FMCG companies nearest to GKB Ophthalmics by market capitalisation.
Ask anything about GKB Ophthalmics
Pivot answers on the live chart with evidence you can check, and tests strategies against GKB's own history. Try: “Why has GKB moved over the last three months?” · “Backtest a 50-day moving-average crossover on GKB over five years” · “Compare GKB with PAOS on margins and valuation”
Frequently asked questions about GKB Ophthalmics
What is the share price of GKB Ophthalmics today?
GKB Ophthalmics (NSE: GKB) last closed at ₹60.00 on 22 Oct 2026. Its 52-week high is ₹76.02 and its 52-week low is ₹58.10.
What is the market cap of GKB Ophthalmics?
GKB Ophthalmics' market capitalisation is ₹30 Cr (₹30 Cr) at the 22 Oct 2026 close, ranking 3368th among the NSE companies Pivot tracks.
What is the P/E ratio of GKB Ophthalmics?
GKB Ophthalmics trades at a trailing P/E of 24.8.
What is the ROE and ROCE of GKB Ophthalmics?
Return on equity was 2.3% in FY26 and return on capital employed was 12.5% in FY26 (consolidated figures).
Is GKB Ophthalmics a debt-free company?
No. GKB Ophthalmics' debt-to-equity ratio was 0.22 in FY26, with total debt of ₹2 Cr.
What were GKB Ophthalmics' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), GKB Ophthalmics reported revenue of ₹30 Cr, −4.0% year on year, and net profit of ₹1 Cr.
What is the shareholding pattern of GKB Ophthalmics?
As of 30 Jun 2026: promoters 51.15%, foreign institutions 1.79%, non-institutions 47.07%.
Who are GKB Ophthalmics' competitors?
The listed FMCG companies closest to GKB Ophthalmics by market cap are Paos Industries, Sinnar Bidi, Times Green, Tyroon Tea, Ambo Agritec and Chordia Food.
Is GKB Ophthalmics a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out GKB Ophthalmics' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on GKB against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all FMCG stocks · companies starting with G · all NSE stocks · this page as text